Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Robert Desantis Sells 376 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Robert Desantis sold 376 shares of the business's stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $375.39, for a total value of $141,146.64. Following the completion of the transaction, the executive vice president now owns 5,507 shares in the company, valued at approximately $2,067,272.73. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Robert Desantis also recently made the following trade(s):

• On Friday, April 26th, Robert Desantis sold 1,498 shares of Intuitive Surgical stock. The shares were sold at an average price of $369.92, for a total transaction of $554,140.16.
• On Monday, March 11th, Robert Desantis sold 329 shares of Intuitive Surgical stock. The shares were sold at an average price of $390.16, for a total transaction of $128,362.64.
• On Friday, March 8th, Robert Desantis sold 20,296 shares of Intuitive Surgical stock. The stock was sold at an average price of $393.80, for a total transaction of $7,992,564.80.

Intuitive Surgical Stock Down 0.9 %

Shares of ISRG stock traded down $3.52 during mid-day trading on Tuesday, reaching $370.62. The stock had a trading volume of 1,212,524 shares, compared to its average volume of 1,644,877. Intuitive Surgical, Inc. has a one year low of $254.85 and a one year high of $403.76. The firm has a market cap of $131.46 billion, a PE ratio of 66.90, a P/E/G ratio of 4.85 and a beta of 1.36. The firm's 50 day simple moving average is $385.96 and its 200 day simple moving average is $348.19.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating analysts' consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business had revenue of $1.89 billion during the quarter, compared to analyst estimates of $1.87 billion. During the same period in the prior year, the company posted $1.00 earnings per share. Intuitive Surgical's revenue was up 11.5% on a year-over-year basis. Sell-side analysts forecast that Intuitive Surgical, Inc. will post 4.8 earnings per share for the current fiscal year.

Analyst Ratings Changes

ISRG has been the subject of a number of analyst reports. Piper Sandler boosted their price target on Intuitive Surgical from $425.00 to $435.00 and gave the stock an "overweight" rating in a research report on Friday, April 19th. Truist Financial upped their target price on Intuitive Surgical from $390.00 to $435.00 and gave the stock a "buy" rating in a research report on Wednesday, January 24th. Citigroup lifted their price target on shares of Intuitive Surgical from $428.00 to $462.00 and gave the company a "buy" rating in a research report on Wednesday, April 3rd. Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an "overweight" rating in a report on Friday, January 19th. Finally, Barclays lifted their target price on shares of Intuitive Surgical from $385.00 to $430.00 and gave the stock an "overweight" rating in a report on Thursday, January 25th. Five analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $396.17.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds have recently made changes to their positions in ISRG. Baystate Wealth Management LLC raised its position in Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider's stock worth $25,000 after purchasing an additional 45 shares in the last quarter. MCF Advisors LLC grew its stake in shares of Intuitive Surgical by 108.1% in the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider's stock valued at $26,000 after purchasing an additional 40 shares during the period. Able Wealth Management LLC acquired a new position in shares of Intuitive Surgical in the 4th quarter worth approximately $28,000. Atticus Wealth Management LLC lifted its position in shares of Intuitive Surgical by 85.4% during the 4th quarter. Atticus Wealth Management LLC now owns 89 shares of the medical equipment provider's stock worth $30,000 after buying an additional 41 shares during the period. Finally, MeadowBrook Investment Advisors LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at $30,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.